These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25127183)

  • 1. Challenges and opportunities in epigenetic drug discovery.
    Cummings RT; Maegley K; Hill WA; Sims R; Mohin S
    Assay Drug Dev Technol; 2014 Oct; 12(8):452-6. PubMed ID: 25127183
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the epigenetic drug discovery landscape.
    Prachayasittikul V; Prathipati P; Pratiwi R; Phanus-Umporn C; Malik AA; Schaduangrat N; Seenprachawong K; Wongchitrat P; Supokawej A; Prachayasittikul V; Wikberg JE; Nantasenamat C
    Expert Opin Drug Discov; 2017 Apr; 12(4):345-362. PubMed ID: 28276705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
    Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
    J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic-targeted drug discovery: from the guest editors.
    Heightman T; Pope A
    J Biomol Screen; 2011 Dec; 16(10):1135-6. PubMed ID: 22156584
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospects for the development of epigenetic drugs for CNS conditions.
    Szyf M
    Nat Rev Drug Discov; 2015 Jul; 14(7):461-74. PubMed ID: 26000723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
    Cacabelos R
    Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of epigenomics on future drug design and new therapies.
    Hamm CA; Costa FF
    Drug Discov Today; 2011 Jul; 16(13-14):626-35. PubMed ID: 21570477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back.
    Bosia M; Pigoni A; Cavallaro R
    Expert Opin Drug Discov; 2015 Feb; 10(2):125-39. PubMed ID: 25345474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural products as catalysts for innovation: a pharmaceutical industry perspective.
    Schmitt EK; Moore CM; Krastel P; Petersen F
    Curr Opin Chem Biol; 2011 Aug; 15(4):497-504. PubMed ID: 21684800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Drug Discovery: Great Potential and Significant Challenges.
    Cummings R
    Assay Drug Dev Technol; 2015 May; 13(4):185. PubMed ID: 26065555
    [No Abstract]   [Full Text] [Related]  

  • 12. Epigenetic treatments for cognitive impairments.
    Day JJ; Sweatt JD
    Neuropsychopharmacology; 2012 Jan; 37(1):247-60. PubMed ID: 21593731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan?
    Vicini P; van der Graaf PH
    Clin Pharmacol Ther; 2013 May; 93(5):379-81. PubMed ID: 23598453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICBS and ECBS Chemical Biology Meeting 2015 - Let Them Come to Berlin!
    Komatsu T; Virdee S
    ACS Chem Biol; 2016 May; 11(5):1159-66. PubMed ID: 27198933
    [No Abstract]   [Full Text] [Related]  

  • 15. Epigenetic opportunities and challenges in cancer.
    Best JD; Carey N
    Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges for academic drug discovery.
    Jorgensen WL
    Angew Chem Int Ed Engl; 2012 Nov; 51(47):11680-4. PubMed ID: 23097176
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences.
    Thomas X
    Expert Opin Drug Discov; 2012 Nov; 7(11):1039-51. PubMed ID: 22950862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymes.
    Zanger UM; Klein K; Thomas M; Rieger JK; Tremmel R; Kandel BA; Klein M; Magdy T
    Clin Pharmacol Ther; 2014 Mar; 95(3):258-61. PubMed ID: 24196843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.